Overview
Vincent Ling focuses his practice on intellectual property litigation, particularly patent infringement and trade secret misappropriation matters. He has significant experience at both the trial and appellate levels.
Vinny advises clients on their most challenging intellectual property issues from the investigation stage all the way through litigation and appeals. He has substantial trial experience in courts nationwide, including in the District of Delaware, Northern District of California, Central District of California and Eastern District of Texas.
He has also worked on high-profile patent appeals, including the reversal of a jury verdict of over $1.2 billion on behalf of Kite Pharma, Inc., a subsidiary of Gilead Sciences, in litigation over the cancer treatment Yescarta®. He is currently counsel for Google in the Federal Circuit’s en banc proceedings in EcoFactor v. Google, relating to the admissibility of damages expert testimony.
Vinny has represented both plaintiffs and defendants in litigation across a range of industries, including computer and networking technologies, semiconductors, banking and finance, and biopharmaceuticals.
Capabilities
Experience
Intellectual Property – Motions Practice and Trials
Google in various patent infringement matters, including
- helping to obtain a complete defense verdict following trial in the District of Delaware over functionality in Google’s Pixel smartphones and mobile apps; and
- securing a favorable settlement in a multi-patent case in the Eastern District of Texas involving tap-and-pay technology.
Intel in cross-border patent litigation involving programmable logic devices in the Western District of Texas and Tokyo District Court, and in IPR proceedings successfully obtaining institution on all claims.
Dell in patent litigation involving a portfolio of Wi-Fi 6 standard-essential patents in the Western District of Texas.
Amgen in obtaining a favorable settlement on the eve of trial, resolving a trade secrets dispute brought against Coherus BioSciences involving the biologic drug Neulasta®.
Applied Materials in a case regarding the alleged misappropriation by former employees of trade secrets relating to the manufacturing of LEDs and lithium-ion batteries. Vinny also represented Applied Materials’ interests as the victim in a related criminal trial resulting in the conviction of a former employee.
PNC Bank, one of the largest banks in the United States, in limiting the damages awarded in multiple patent infringement lawsuits filed by United Services Automobile Association (USAA) in the Eastern District of Texas relating to remote check deposit technology.
Checkr, Inc. in a matter defending against allegations of trade secrets theft, unfair competition and breach of contract.
YipitData, a subsidiary of the Carlyle Group, in bringing an action for trade secret misappropriation in the Southern District of New York.
Intellectual Property – Appeals
Google in en banc proceedings at the Federal Circuit in EcoFactor v. Google, relating to the admissibility of expert testimony on patent damages.
Kite Pharma, Inc., a subsidiary of Gilead Sciences, in helping to win a high-stakes intellectual property battle at the Federal Circuit and Supreme Court, overturning a multi-billion-dollar judgment over the cancer treatment Yescarta®.
More
- American Inns of Court, Linn Inn Alliance Distinguished Service Medal, 2025
- The Best Lawyers in America, “Ones to Watch,” 2023-2025
Vinny represented a former federal employee appealing a final order from the Merit Systems Protection Board (Arellanes v. Department of Defense).
- President (2024-current); past Membership Chair (2023-2024); past Program Co-Chair (2022-2023) of the Judge Paul R. Michel Intellectual Property American Inn of Court
- Past Chair (2021-2022) and past Co-Chair (2022-2023), Patent and Trade Secrets Committee of the Los Angeles Intellectual Property Law Association (LAIPLA)
- Member, Federal Circuit Bar Association
Publications
- Co-author, “Trade Secret Law and AI: Navigating Emerging Risks and Legal Implications,” Daily Journal, July 24, 2024, with Miriam Kim and Nate Sussman
- “Litigation Strategies for When Trade Secret, Patent Converge,” Law 360, July 16, 2020
- Co-author, “Practice Guide to Section 285 ‘Exceptional Case’ Findings,” American Bar Association, Intellectual Property Litigation Newsletter, January 2016
- Co-author, “UPC Recap: Have You Been Paying Attention?,” Intellectual Property Magazine, February 2015
